Efficacy and safety of PARP inhibitor maintenance therapy in elderly ovarian cancer patients: a real-world single-center retrospective cohort study - Top-Institutions - MDSpire

Efficacy and safety of PARP inhibitor maintenance therapy in elderly ovarian cancer patients: a real-world single-center retrospective cohort study

By
Jingjing Lu
Xuelian Song
Chen Zhang
Yi Zhu
Huarui Yang
Yi Li
June 8, 2026
0 min

Frontiers In Oncology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Peking University People’s Hospital

Beijing, Beijing
Key Differentiators
- Oncology
#2

People’s Hospital of Peking University

Beijing, Beijing
Key Differentiators
- Oncology
#3

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania
Key Differentiators
- Oncology
#4

Froedtert and Medical College of Wisconsin

Milwaukee, Wisconsin
Key Differentiators
- Oncology
#5

Johns Hopkins Medicine

Baltimore, Maryland
Key Differentiators
- Oncology

Original Source(s)

Frontiers In Oncology

Efficacy and safety of PARP inhibitor maintenance therapy in elderly ovarian cancer patients: a real-world single-center retrospective cohort study

by Jingjing Lu, Xuelian Song, Chen Zhang, Yi Zhu, Huarui Yang, Yi Li
June 8, 2026

Related Content

Frontiers In Medicine

Lymphocyte CD4/CD8 ratio predicts early immune-related toxicity in lung cancer patients treated with immune checkpoint inhibitors: a single-center retrospective study

by Wenfang Jin, Ying Zhao, Yanling Lv, Yu Yao, Xin Su
June 8, 2026

Frontiers In Oncology

Recurrent intracranial hemorrhage without brain metastasis after VEGFR TKI rechallenge in metastatic renal cell carcinoma: a case report and literature review

by Chang-Hoon Lee, Na-Ri Lee
June 8, 2026

Frontiers In Endocrinology

S-GRAS score and the complementary prognostic value of neutrophil-to-lymphocyte ratio in adrenocortical carcinoma: evidence for a synergistic interaction